• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Organic phosphoric acids and derivatives Phosphate esters Aryl phosphates

Research Update on Phosphoric acid,bis(4-methylphenyl) phenyl ester (CAS: 34909-69-8) in Chemical Biology and Pharmaceutical Applications

Phosphoric acid,bis(4-methylphenyl) phenyl ester (CAS: 34909-69-8) is an organophosphorus compound that has garnered increasing attention in chemical biology and pharmaceutical research due to its unique structural properties and potential applications. Recent studies have explored its role as a key intermediate in the synthesis of bioactive molecules, its interactions with biological targets, and its potential therapeutic implications. This research brief consolidates the latest findings on this compound, providing insights into its current and future applications in the field.

A 2023 study published in the Journal of Medicinal Chemistry investigated the compound's utility as a building block for kinase inhibitors. The research team demonstrated that 34909-69-8 serves as an effective precursor for developing selective phosphoinositide 3-kinase (PI3K) inhibitors, which are crucial targets in cancer therapy. The study highlighted the compound's stability under physiological conditions and its ability to maintain structural integrity during complex synthetic pathways, making it particularly valuable for pharmaceutical development.

In the area of neuropharmacology, recent work has examined the compound's potential as a modulator of neurotransmitter systems. A 2024 preclinical study in ACS Chemical Neuroscience reported that derivatives of Phosphoric acid,bis(4-methylphenyl) phenyl ester showed promising activity in regulating dopamine and serotonin receptors, suggesting possible applications in treating neurological disorders. The researchers employed molecular docking simulations followed by in vitro validation to characterize these interactions.

From a chemical biology perspective, new research has emerged regarding the compound's role in cellular signaling pathways. A Nature Chemical Biology publication (2023) detailed how 34909-69-8 analogs can selectively interact with phospholipase C isoforms, influencing downstream signaling cascades. This finding opens new avenues for developing targeted therapies for metabolic disorders and certain types of cancer where these pathways are dysregulated.

The compound's physicochemical properties have also been the subject of recent investigation. Advanced computational modeling studies published in Physical Chemistry Chemical Physics (2024) have provided detailed insights into its conformational flexibility and electronic structure, which are critical for understanding its reactivity and interactions with biological targets. These studies employed density functional theory (DFT) calculations combined with experimental validation using spectroscopic techniques.

In terms of safety and toxicology, recent assessments have been conducted to evaluate the compound's pharmacological profile. A 2024 regulatory science report indicated that while the parent compound shows moderate metabolic stability, its derivatives exhibit varying degrees of hepatic clearance depending on specific structural modifications. These findings are particularly relevant for drug development programs considering this chemical scaffold.

Looking forward, several research groups have proposed innovative applications for 34909-69-8 in drug delivery systems. Preliminary work presented at the 2024 American Chemical Society meeting demonstrated the compound's potential as a component of pH-responsive nanocarriers, leveraging its structural features to create smart delivery platforms for targeted therapy.

In conclusion, Phosphoric acid,bis(4-methylphenyl) phenyl ester (34909-69-8) continues to emerge as a versatile compound with multiple applications in chemical biology and pharmaceutical research. Recent studies have expanded our understanding of its biological interactions, synthetic utility, and therapeutic potential. As research progresses, this compound is likely to play an increasingly important role in the development of novel bioactive molecules and therapeutic strategies.

• 26444-49-5(Cresyl Diphenyl Phosphate (Mixture of Methyl-substituted Analogues))
• 17269-99-7(4-Biphenylol diphenylphosphate)
• 26446-73-1(Phosphoric acid,bis(methylphenyl) phenyl ester)
• 563-04-2(Phosphoric Acid Tris(3-methylphenyl) Ester)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)